Clinical Trial Update: Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of Azficel-T for restrictive burn scars was terminated; results were posted in 2021. No efficacy conclusions are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restrictive Burn Scar

Drugs mentioned

• Azficel-T (Azficel-T)

Snippet

Sponsor: Castle Creek Biosciences, LLC. | Conditions: Restrictive Burn Scars | Phase 2 | Status: TERMINATED | Results posted: 2021-07-19